MedPath

Women's Hospital School of Medicine Zhejiang University,Zhejiang Women's

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Evaluation of PLD Combined With Carboplatin Versus Paclitaxel Plus Carboplatin in the First-line Treatment of Epithelial Ovarian Cancer

Phase 4
Conditions
Efficacy and Safety
Interventions
First Posted Date
2019-01-07
Last Posted Date
2022-07-18
Lead Sponsor
Women's Hospital School Of Medicine Zhejiang University
Target Recruit Count
396
Registration Number
NCT03794778
Locations
🇨🇳

Women's Hospital School Of Medicine Zhejiang University, Zhejiang, Hangzhou, China

Study of Different Therapeutic Strategies in Hydatidiform Mole With Lung Nodule

Not Applicable
Recruiting
Conditions
Hydatidiform Mole
Gestational Trophoblastic Neoplasia
Interventions
Drug: chemotherapy
Other: Follow up
First Posted Date
2018-12-24
Last Posted Date
2025-05-30
Lead Sponsor
Women's Hospital School Of Medicine Zhejiang University
Target Recruit Count
30
Registration Number
NCT03785574
Locations
🇨🇳

Weiguo Lv, Hangzhou, Zhejiang, China

Study of Hysteroscopic Repeat Curettage as the First-line Treatment in Low-risk Postmolar Gestational Trophoblastic Neoplasia

Phase 3
Conditions
Gestational Trophoblastic Neoplasia
Interventions
Procedure: hysteroscopic repeat curettage
First Posted Date
2018-10-11
Last Posted Date
2022-07-18
Lead Sponsor
Women's Hospital School Of Medicine Zhejiang University
Target Recruit Count
214
Registration Number
NCT03703271
Locations
🇨🇳

Weiguo Lv, Hangzhou, Zhejiang, China

© Copyright 2025. All Rights Reserved by MedPath